Please check your internet connection and try again.
# Lorazepam (representative benzodiazepine)
## Overview
Lorazepam is a short-acting benzodiazepine with anxiolytic, sedative, amnestic, anticonvulsant, and muscle relaxant properties. It acts by enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) in the central nervous system.
## Primary Indications
* **Anxiety disorders:** Management of anxiety symptoms.
* **Insomnia:** Short-term treatment of sleep disturbances.
* **Status epilepticus:** First-line treatment for prolonged seizures.
* **Preoperative sedation:** To reduce anxiety and promote amnesia prior to surgical procedures.
* **Management of agitation:** Acute agitation.
## Adult Dosing
* **Anxiety:** 1-4 mg orally or IM every 6-8 hours as needed. Maximum daily dose typically 10 mg.
* **Insomnia:** 2-4 mg orally at bedtime.
* **Status Epilepticus:** 4 mg IV or IM. Repeat in 5-10 minutes if seizures persist. Maximum initial dose 8 mg.
* **Preoperative sedation:** 2-4 mg IM 2 hours before surgery.
* **Agitation:** 0.5-2 mg orally or IM every 4-6 hours as needed. Dosing should be individualized.
## Pediatric Dosing
Dosing in pediatrics is highly variable and should be determined based on institutional protocols, patient weight, and clinical condition.
* **Status Epilepticus:** 0.1 mg/kg IV/IM, maximum 4 mg per dose. Repeat once after 5-10 minutes if necessary. (Some guidelines suggest up to 0.2 mg/kg, max 10 mg).
## Dose Adjustments
* **Hepatic Impairment:** Use with caution and consider reduced doses due to potential accumulation.
* **Renal Impairment:** No specific dose adjustment is routinely recommended, but caution is advised, especially in severe impairment.
* **Elderly:** Reduce initial doses by 50% and titrate cautiously due to increased sensitivity and risk of adverse effects.
## Contraindications
* Known hypersensitivity to lorazepam, other benzodiazepines, or any component of the formulation.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe liver dysfunction.
* Sleep apnea.
## Adverse Effects
Common: Drowsiness, sedation, dizziness, fatigue, unsteadiness, weakness.
Serious: Respiratory depression, paradoxical reactions (agitation, excitement), anterograde amnesia, dependence, withdrawal symptoms upon abrupt discontinuation.
## Key Drug Interactions
* **CNS Depressants (opioids, alcohol, other sedatives):** Additive CNS depression, increased risk of respiratory depression and profound sedation. Extreme caution and dose reduction are warranted.
* **CYP450 Enzyme Inducers/Inhibitors:** Lorazepam is primarily metabolized by glucuronidation, not extensively by CYP450 enzymes, leading to fewer significant CYP-mediated drug interactions compared to some other benzodiazepines. However, caution is still advised with drugs that may affect GABAergic transmission.
## Monitoring
* Level of consciousness, respiratory rate, and oxygen saturation.
* Signs of paradoxical reactions or agitation.
* Signs of dependence or withdrawal if used long-term.
* Effectiveness of treatment for the specific indication.
## Clinical Pearls
* For status epilepticus, IV administration is preferred if available, providing faster onset of action.
* Avoid abrupt discontinuation, especially after prolonged use, to prevent withdrawal symptoms. Tapering is recommended.
* Elderly patients are more susceptible to the adverse effects of lorazepam, including falls and cognitive impairment.
* Lorazepam injection contains polyethylene glycol and propylene glycol, which can cause toxicity in patients with renal or hepatic impairment, or in neonates.
**Disclaimer:** This information is intended for healthcare professionals. Always consult the official prescribing information and relevant clinical guidelines for complete and up-to-date information before making any treatment decisions.
